机器人辅助胃癌手术在争议中前行

Robot‑assisted gastric cancer surgery move forward in controversy

  • 摘要: 胃癌是我国目前发病率和病死率均位列第3的恶性肿瘤,手术是提高患者预后的重要治疗手段。机器人辅助手术作为微创技术之一,近几十年在我国经历飞速发展,同时也伴随争议。近年来以中国、日本、韩国为主的亚洲国家开展大量高质量临床研究,旨在评估机器人手术系统辅助胃癌手术的安全性和有效性。笔者总结上述研究结果及团队实践经验,相信随着技术的不断进步,机器人手术系统在胃癌治疗中将会得到广泛应用。

     

    Abstract: Gastric cancer is a malignant tumor with morbidity and mortality ranking the third in China. Surgical treatment is an important therapy to improve the prognosis of patients. Robot‑assisted surgery, as a minimally invasive technique, has experienced rapid development in China in recent decades, but has also caused a lot of controversy. In recent years, a large number of high‑quality clinical studies have been carried out in Asian countries, mainly in China, Japan and South Korea, to evaluate the safety and effectiveness of robot‑assisted gastric cancer surgery. The authors summarize the above research results and their work experience with robot‑assisted gastric cancer surgery. We believe that robotic surgery will be widely used in the treatment of gastric cancer with the continuous progress of technology.

     

/

返回文章
返回